| Metric | Value (₹ Cr) | vs Q2 FY26 |
|---|---|---|
| Revenue | 0.38 | |
| Total Income | 0.40 | 4554.6% |
| Expenditure | 0.32 | 374.5% |
| PBT | 0.08 | 240.0% |
| Net Profit | 0.08 | 240.0% |
| OPM | 20.00% | |
| NPM | 20.46% | |
| EPS | 0.08 | 33.3% |
Hindustan Bio Sciences Ltd Announces Q3 2025 Results with 31% YoY Revenue Growth
31 Jan 2026 · 31 Jan, 4:02 pm
Summary
Hindustan Bio Sciences Ltd has announced its Q3 2025 results with a 31% YoY revenue growth. The company's un-audited financial results for the quarter ended 31st December, 2025 were approved at the Board Meeting held on 31st January, 2026.
Key Highlights
- 1
Q3 2025 Results with 31% YoY Revenue Growth
- 2
Un-audited financial results for the quarter ended 31st December, 2025 approved
- 3
Limited Review Report for the quarter ended 31st December, 2025
Management Comments
N
Not Provided
Not Provided
Informational and educational content only. Not investment advice.